Clinical Trial Update: Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease [Phase 2]

View source ↗

Summary

This update reports a Phase 2 clinical trial of levetiracetam for managing levodopa-induced dyskinesias in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: 1st Hospital of Social Security Services | Conditions: Levodopa Induced Dyskinesia | Phase 2 | Status: UNKNOWN